Overview

The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years.

Full Product Details

Author:   Joel Lexchin
Publisher:   University of Toronto Press
Imprint:   University of Toronto Press
Dimensions:   Width: 15.40cm , Height: 2.30cm , Length: 22.90cm
Weight:   0.590kg
ISBN:  

9781442626591

ISBN 10:   1442626593
Pages:   384
Publication Date:   21 September 2016
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Temporarily unavailable  
The supplier advises that this item is temporarily unavailable. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out to you.

Table of Contents

Abbreviations Boxes, Tables and Figures Introduction: Why do we care about the pharmaceutical industry in Canada? Chapter 1: (De)regulation through cooperation Chapter 2: Biased testing, hidden results and the regulation of clinical trials Chapter 3: Approving new drugs: better or just more? Chapter 4: Regulating promotion or licensing deception? Chapter 5: Health Canada and drug safety: how safe are we? Chapter 6: Is intellectual property a right? Chapter 7: How revenue is generated: prices, volume, mix and overall spending Chapter 8: Who gets the value from research and development? Chapter 9: Canada, the pharmaceutical industry and access to medicines in the Global South Chapter 10: Courage my friends; ’tis not too late to build a better world Acknowledgements

Reviews

"""Joel Lexchin has written a very thorough overview of the Canadian history of public policy and the pharmaceutical industry. This work is a testament to the author's standing as a world expert in this area.""--James McCormack, Faculty of Pharmaceutical Sciences, University of British Columbia ""Private Profits versus Public Policy is a very interesting and well-referenced work. It offers a wealth of information in a field of work where hard information is difficult to gather.""--Nuria Homedes, School of Public Health, University of Texas"

Private Profits versus Public Policy is a very interesting and well-referenced work. It offers a wealth of information in a field of work where hard information is difficult to gather. - Nuria Homedes, School of Public Health, University of Texas Joel Lexchin has written a very thorough overview of the Canadian history of public policy and the pharmaceutical industry. This work is a testament to the author's standing as a world expert in this area. - James McCormack, Faculty of Pharmaceutical Sciences, University of British Columbia

Author Information

Joel Lexchin is a Fellow of the Canadian Academy of Health Sciences. He is a professor in the School of Health Policy and Management at York University and works as an emergency physician at the University Health Network.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions